All data are based on the daily closing price as of October 8, 2025
i

Ildong Pharmaceutical

249420.KO
19.41 USD
-1.34
-6.46%

Overview

Last close
19.41 usd
Market cap
613.86M usd
52 week high
24.22 usd
52 week low
7.11 usd
Target price
35.07 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
1.4621
Price/Book Value
5.2703
Enterprise Value
701.24M usd
EV/Revenue
1.7056
EV/EBITDA
38.6113

Key financials

Revenue TTM
411.14M usd
Gross Profit TTM
155.28M usd
EBITDA TTM
28.16M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
431.35M usd
Net debt
91.36M usd

About

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system applications. It also provides raw material drugs; health foods and foods; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products. In addition, the company manages licenses and provides contract manufacturing services. It also exports its products to approximately 20 countries worldwide. Ildong Pharmaceutical Co., Ltd. a strategic collaboration with Evotec SE to accelerate the development of various Ildong's proprietary projects through access to Evotec's INDiGO platform. The company was founded in 1941 and is headquartered in Seoul, South Korea.
  • Symbol
    249420.KO
  • Exchange
    KO
  • Isin
    KR7249420001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Yun Paul Woongsup
  • Headquarter
    Seoul
  • Web site
    https://www.ildong.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top